DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Phase 2

Completed

Conditions: Lung Cancer

First Posted Date: 2008-05-07

Last Posted Date: 2010-08-09

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 40

Registration Number: NCT00673569

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy

Not Applicable

Completed

Conditions: Pain
Hematopoietic/Lymphoid Cancer

Interventions: Other: questionnaire administration
Procedure: acupressure therapy
Procedure: biopsy
Procedure: bone marrow aspiration
Procedure: pain therapy

First Posted Date: 2008-05-02

Last Posted Date: 2018-06-28

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 83

Registration Number: NCT00670917

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Other: standard of care follow-up
Drug: valproic acid

First Posted Date: 2008-05-01

Last Posted Date: 2018-09-28

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 15

Registration Number: NCT00670046

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer

Not Applicable

Terminated

Conditions: Pain
Pancreatic Cancer

Interventions: Device: Medtronic intrathecal pump
Drug: morphine sulfate

First Posted Date: 2008-04-17

Last Posted Date: 2014-10-08

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 1

Registration Number: NCT00660348

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer

Phase 1

Completed

Conditions: Colorectal Cancer
Metastatic Cancer

Interventions: Biological: Colon GVAX
Drug: cyclophosphamide

First Posted Date: 2008-04-10

Last Posted Date: 2019-08-14

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 9

Registration Number: NCT00656123

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma

Not Applicable

Terminated

Conditions: Brain and Central Nervous System Tumors
Musculoskeletal Complications

Interventions: Drug: testosterone gel applied to skin
Dietary Supplement: whey powder protein

First Posted Date: 2008-03-07

Last Posted Date: 2018-08-27

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 1

Registration Number: NCT00631137

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

Phase 2

Active, not recruiting

Conditions: Breast Cancer

Interventions: Drug: carboplatin
Drug: paclitaxel albumin-stabilized nanoparticle formulation
Other: placebo
Drug: vorinostat

First Posted Date: 2008-02-15

Last Posted Date: 2025-02-27

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 68

Registration Number: NCT00616967

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Indiana University Purdue University of Indianapolis, Indianapolis, Indiana, United States

and more 2 locations

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Phase 1

Completed

Conditions: Multiple Myeloma and Plasma Cell Neoplasm

Interventions: Biological: MILs
Drug: Melphalan
Biological: PCV13

First Posted Date: 2007-12-03

Last Posted Date: 2023-05-26

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 26

Registration Number: NCT00566098

Locations: 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Docetaxel

First Posted Date: 2007-11-16

Last Posted Date: 2008-12-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 13

Registration Number: NCT00559429

Locations: 🇺🇸
The Harry and Jeanette Weinberg Building, Baltimore, Maryland, United States

Musculoskeletal Outcomes After Bone Marrow Transplant

Completed

Conditions: Survivors of Bone Marrow Transplant
Autologous and Allogeneic

First Posted Date: 2007-11-16

Last Posted Date: 2009-08-19

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 48

Registration Number: NCT00558948

Locations: 🇺🇸
Johns Hopkins University, Bayview Campus, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy